Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients
Clinical trial NCT03022097 · COMPLETED
Trial details
- NCT number
- NCT03022097
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2022-04-14
- Enrollment
- 1625
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.